103 related articles for article (PubMed ID: 38960841)
1. Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status.
Durda-Masny M; Goździk-Spychalska J; Morańska K; Pawłowska N; Mazurkiewicz M; Skrzypczak I; Cofta S; Szwed A
J Cyst Fibros; 2024 Jul; ():. PubMed ID: 38960841
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
3. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
4. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
5. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiota in adults with cystic fibrosis compared to colorectal cancer.
Caley LR; Wood HM; Bottomley D; Fuentes Balaguer A; Wilkinson L; Dyson J; Young C; White H; Benton S; Brearley M; Quirke P; Peckham DG
J Cyst Fibros; 2024 Mar; 23(2):262-268. PubMed ID: 38104000
[TBL] [Abstract][Full Text] [Related]
7. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
9. Development of the intestinal microbiome in cystic fibrosis in early life.
Price CE; Hampton TH; Valls RA; Barrack KE; O'Toole GA; Madan JC; Coker MO
mSphere; 2023 Aug; 8(4):e0004623. PubMed ID: 37404016
[TBL] [Abstract][Full Text] [Related]
10. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
11. Modulation, microbiota and inflammation in the adult CF gut: A prospective study.
Ronan NJ; Einarsson GG; Deane J; Fouhy F; Rea M; Hill C; Shanahan F; Elborn JS; Ross RP; McCarthy M; Murphy DM; Eustace JA; Mm T; Stanton C; Plant BJ
J Cyst Fibros; 2022 Sep; 21(5):837-843. PubMed ID: 35764510
[TBL] [Abstract][Full Text] [Related]
12. Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R; Dos Santos C; Hanson L; Ng C; Major G; Smyth AR; Rivett D; van der Gast C
Microbiol Spectr; 2023 Aug; 11(5):e0117523. PubMed ID: 37607068
[TBL] [Abstract][Full Text] [Related]
13. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
16. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
17. Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation.
Hahn A; Burrell A; Ansusinha E; Peng D; Chaney H; Sami I; Perez GF; Koumbourlis AC; McCarter R; Freishtat RJ; Crandall KA; Zemanick ET
Heliyon; 2020 Jun; 6(6):e04104. PubMed ID: 32514485
[TBL] [Abstract][Full Text] [Related]
18. Intestinal
Price CE; Valls RA; Ramsey AR; Loeven NA; Jones JT; Barrack KE; Schwartzman JD; Royce DB; Cramer RA; Madan JC; Ross BD; Bliska J; O'Toole GA
mBio; 2024 Feb; 15(2):e0314423. PubMed ID: 38179971
[TBL] [Abstract][Full Text] [Related]
19. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
20. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]